Literature DB >> 10496932

Tumor necrosis factor (TNF) and a TNF-mimetic peptide modulate the granulomatous response to Mycobacterium bovis BCG infection in vivo.

D R Roach1, H Briscoe, K Baumgart, D A Rathjen, W J Britton.   

Abstract

Tumor necrosis factor (TNF) is a critical mediator in the immune response to mycobacteria, particularly in the formation and maintenance of granulomas. Treatment of Mycobacterium bovis BCG-infected mice with TNF and a TNF-mimetic peptide (TNF(70-80)) altered the number and cellular composition of granulomas. This change was associated with a moderate decrease in the bacterial burden.

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10496932      PMCID： PMC96907          DOI： 10.1128/IAI.67.10.5473-5476.1999

Source DB:  PubMed          Journal:  Infect Immun        ISSN： 0019-9567            Impact factor:   3.441


  20 in total

1.  The immunopathogenesis of tuberculosis: a new working hypothesis.

Authors:  I M Orme
Journal:  Trends Microbiol       Date:  1998-03       Impact factor: 17.079

2.  Protection of mice against Listeria monocytogenes infection by recombinant human tumor necrosis factor alpha.

Authors:  J V Desiderio; P A Kiener; P F Lin; G A Warr
Journal:  Infect Immun       Date:  1989-05       Impact factor: 3.441

3.  A tumor necrosis factor mimetic peptide activates a murine macrophage cell line to inhibit mycobacterial growth in a nitric oxide-dependent fashion.

Authors:  W J Britton; N Meadows; D A Rathjen; D R Roach; H Briscoe
Journal:  Infect Immun       Date:  1998-05       Impact factor: 3.441

4.  Structural deficiencies in granuloma formation in TNF gene-targeted mice underlie the heightened susceptibility to aerosol Mycobacterium tuberculosis infection, which is not compensated for by lymphotoxin.

Authors:  A G Bean; D R Roach; H Briscoe; M P France; H Korner; J D Sedgwick; W J Britton
Journal:  J Immunol       Date:  1999-03-15       Impact factor: 5.422

5.  A synthetic tumor necrosis factor-alpha agonist peptide enhances human polymorphonuclear leukocyte-mediated killing of Plasmodium falciparum in vitro and suppresses Plasmodium chabaudi infection in mice.

Authors:  L M Kumaratilake; D A Rathjen; P Mack; F Widmer; V Prasertsiriroj; A Ferrante
Journal:  J Clin Invest       Date:  1995-05       Impact factor: 14.808

6.  Tumor necrosis factor-alpha is required in the protective immune response against Mycobacterium tuberculosis in mice.

Authors:  J L Flynn; M M Goldstein; J Chan; K J Triebold; K Pfeffer; C J Lowenstein; R Schreiber; T W Mak; B R Bloom
Journal:  Immunity       Date:  1995-06       Impact factor: 31.745

7.  Distribution of mycobacteria grown in vivo in the organs of intravenously infected mice.

Authors:  F M Collins; V Montalbine
Journal:  Am Rev Respir Dis       Date:  1976-03

8.  Exacerbation of acute and chronic murine tuberculosis by administration of a tumor necrosis factor receptor-expressing adenovirus.

Authors:  L B Adams; C M Mason; J K Kolls; D Scollard; J L Krahenbuhl; S Nelson
Journal:  J Infect Dis       Date:  1995-02       Impact factor: 5.226

9.  The inducing role of tumor necrosis factor in the development of bactericidal granulomas during BCG infection.

Authors:  V Kindler; A P Sappino; G E Grau; P F Piguet; P Vassalli
Journal:  Cell       Date:  1989-03-10       Impact factor: 41.582

10.  An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection.

Authors:  J L Flynn; J Chan; K J Triebold; D K Dalton; T A Stewart; B R Bloom
Journal:  J Exp Med       Date:  1993-12-01       Impact factor: 14.307
View more
  9 in total

1.  Differential effects of total and partial neutralization of tumor necrosis factor on cell-mediated immunity to Mycobacterium bovis BCG infection.

Authors:  Reto Guler; Maria L Olleros; Dominique Vesin; Roumen Parapanov; Irene Garcia
Journal:  Infect Immun       Date:  2005-06       Impact factor: 3.441

2.  Recombinant guinea pig tumor necrosis factor alpha stimulates the expression of interleukin-12 and the inhibition of Mycobacterium tuberculosis growth in macrophages.

Authors:  Hyosun Cho; Todd M Lasco; Shannon Sedberry Allen; Teizo Yoshimura; David N McMurray
Journal:  Infect Immun       Date:  2005-03       Impact factor: 3.441

3.  Immunopathologic effects of tumor necrosis factor alpha in murine mycobacterial infection are dose dependent.

Authors:  L G Bekker; A L Moreira; A Bergtold; S Freeman; B Ryffel; G Kaplan
Journal:  Infect Immun       Date:  2000-12       Impact factor: 3.441

4.  Evaluation of memory immune response to mycobacterium extract among household contact of tuberculosis cases.

Authors:  Y V N Cavalcanti; V R A Pereira; L C Reis; A L G Ramos; C F Luna; E J M Nascimento; N Lucena-Silva
Journal:  J Clin Lab Anal       Date:  2009       Impact factor: 2.352

5.  In situ study of abundant expression of proinflammatory chemokines and cytokines in pulmonary granulomas that develop in cynomolgus macaques experimentally infected with Mycobacterium tuberculosis.

Authors:  Craig L Fuller; JoAnne L Flynn; Todd A Reinhart
Journal:  Infect Immun       Date:  2003-12       Impact factor: 3.441

6.  Effect of recombinant Mce4A protein of Mycobacterium bovis on expression of TNF-alpha, iNOS, IL-6, and IL-12 in bovine alveolar macrophages.

Authors:  Guangxian Xu; Yuxing Li; Jianmin Yang; Xiangmei Zhou; Xiaomin Yin; Meili Liu; Deming Zhao
Journal:  Mol Cell Biochem       Date:  2007-05-26       Impact factor: 3.396

7.  Prokaryotic expression and functional analysis of the Mb1514 gene in Mycobacterium bovis.

Authors:  Xiaomin Yin; Xiangmei Zhou; Zhixin Xue; Lihong Tian; Yang Zhou; Lifeng Yang; Deming Zhao
Journal:  Mol Cell Biochem       Date:  2013-10-20       Impact factor: 3.396

8.  Granuloma transplantation: an approach to study mycobacterium-host interactions.

Authors:  Jeffrey S Harding; Heidi A Schreiber; Matyas Sandor
Journal:  Front Microbiol       Date:  2011-12-12       Impact factor: 5.640

Review 9.  Three-dimensional in vitro models of granuloma to study bacteria-host interactions, drug-susceptibility, and resuscitation of dormant mycobacteria.

Authors:  Liam E Fitzgerald; Naiara Abendaño; Ramon A Juste; Marta Alonso-Hearn
Journal:  Biomed Res Int       Date:  2014-05-21       Impact factor: 3.411
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.